Human Squalamine Derivatives Patent, Enterin, Inc., Apr 15
Summary
The European Patent Office published application EP4007765A1 on April 15, 2026, covering human squalamine derivatives and related pharmaceutical compositions. The patent applicants are Enterin, Inc., with inventors Denise BARBUT and Michael ZASLOFF. The application is classified under multiple IPC codes spanning steroid derivatives (C07J), medicinal preparations (A61K), and therapeutic indications including neurological (A61P 25/00) and cardiovascular (A61P 9/10) applications, and designates all European extension states (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR).
About this source
GovPing monitors EPO Patent Bulletin - Therapeutics (A61P) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 24 changes logged to date.
What changed
The EPO published patent application EP4007765A1 covering human squalamine derivatives, related compositions, and methods of using the same. The application names Enterin, Inc. as the applicant and lists Denise BARBUT and Michael ZASLOFF as inventors. Key IPC classifications include steroid derivatives (C07J 41/00), medicinal preparations containing steroids (A61K 31/575), and therapeutic uses targeting neurological (A61P 25/00) and cardiovascular (A61P 9/10) conditions.
Pharmaceutical companies and drug manufacturers developing aminosterol or squalamine-based therapeutics should review this publication to assess potential freedom-to-operate implications in the EU market, particularly for neurological and cardiovascular indications covered by the designated states.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
HUMAN SQUALAMINE DERIVATIVES, RELATED COMPOSITIONS COMPRISING THE SAME, AND METHODS OF USING THE SAME
Publication EP4007765A1 Kind: A1 Apr 15, 2026
Applicants
Enterin, Inc.
Inventors
BARBUT, Denise, ZASLOFF, Michael
IPC Classifications
C07J 41/00 20060101AFI20250611BHEP A61K 31/575 20060101ALI20250611BHEP A61K 47/26 20060101ALI20250611BHEP A61K 47/10 20170101ALI20250611BHEP A61P 25/00 20060101ALI20250611BHEP A61P 9/10 20060101ALI20250611BHEP A61K 9/00 20060101ALI20250611BHEP A61K 45/06 20060101ALI20250611BHEP C07J 9/00 20060101ALI20250611BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.